BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27848167)

  • 1. Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.
    Ma P; Yu H; Zhang X; Mu H; Chu Y; Ni L; Xing P; Wang Y; Sun K
    Pharm Res; 2017 Jan; 34(1):121-135. PubMed ID: 27848167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
    Li J; Zhang X; Wang M; Li X; Mu H; Wang A; Liu W; Li Y; Wu Z; Sun K
    Int J Pharm; 2016 Mar; 501(1-2):112-23. PubMed ID: 26828670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
    Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
    Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
    Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
    Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
    Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
    Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
    Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
    Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment.
    Yang X; Wang L; Li L; Han M; Tang S; Wang T; Han J; He X; He X; Wang A; Sun K
    Drug Deliv; 2019 Dec; 26(1):989-1001. PubMed ID: 31571502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-sensitive cytotoxic peptide-dendrimer conjugates enhance cell apoptosis and deep tumor penetration.
    Liu FH; Hou CY; Zhang D; Zhao WJ; Cong Y; Duan ZY; Qiao ZY; Wang H
    Biomater Sci; 2018 Feb; 6(3):604-613. PubMed ID: 29406549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
    Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents].
    Kong SY; Tang GT; Pei YY; Jiang YY
    Yao Xue Xue Bao; 2009 Jan; 44(1):85-90. PubMed ID: 19350828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
    Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
    Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
    Singh P; Gupta U; Asthana A; Jain NK
    Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer.
    Rompicharla SVK; Kumari P; Bhatt H; Ghosh B; Biswas S
    Int J Pharm; 2019 Feb; 557():329-341. PubMed ID: 30599231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
    Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
    Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
    Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
    Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.